Athanor Capital, LP Amicus Therapeutics, Inc. Transaction History

Athanor Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $212,846 - $261,964	-24,437 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $431,645 - $1.12 Million	-46,918 Reduced 65.75%	24,437 $241,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $341,195 - $630,463	25,330 Added 55.04%	71,355 $1.65 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $534,174 - $658,497	-41,441 Reduced 47.38%	46,025 $650,000
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $774,948 - $1.37 Million	87,466 New	87,466 $1.32 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $522,444 - $879,408	-78,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $205,999 - $296,055	27,540 Added 53.73%	78,800 $768,000
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $411,105 - $679,195	51,260 New	51,260 $411,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.